Removal or revision of vaginal mesh used for the treatment of stress urinary incontinence

JAMA Surgery

Volumn 150, Issue 12, 2015, Pages 1167-1175

  Welk, Blayne ^a   Al Hothi, Hana'a ^b,c   Winick Ng, Jennifer ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; DEVICE REMOVAL; EROSION; FEMALE; FISTULA; GYNECOLOGIST; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MESH SLING; PAIN; PATIENT RISK; PRIORITY JOURNAL; REOPERATION; RISK REDUCTION; STRESS INCONTINENCE; SURGEON; SURGICAL RISK; SURVIVAL RATE; UROLOGIST; ADVERSE EFFECTS; FOLLOW UP; MIDDLE AGED; ONTARIO; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RETROSPECTIVE STUDY; SURGICAL MESH; TIME FACTOR; URINARY INCONTINENCE, STRESS; VAGINA;

DEVICE REMOVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; ONTARIO; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; SURGICAL MESH; TIME FACTORS; URINARY INCONTINENCE, STRESS; VAGINA;

EID: 84950248223     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2015.2590     Document Type: Article

References (41)

1. Nygaard I, Barber MD, Burgio KL, et al; Pelvic Floor Disorders Network. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311-1316.
2. Wu JM, Matthews CA, Conover MM, Pate V, Jonsson Funk M. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol. 2014;123(6):1201-1206.
3. Oliphant SS, Wang L, Bunker CH, Lowder JL. Trends in stress urinary incontinence inpatient procedures in the United States, 1979-2004. Am J Obstet Gynecol. 2009;200(5):521.e1-521.e6. doi:10.1016/j.ajog.2009.01.007.
4. Chughtai BI, Elterman DS, Vertosick E, Maschino A, Eastham JA, Sandhu JS. Midurethral sling is the dominant procedure for female stress urinary incontinence: analysis of case logs from certifying American urologists. Urology. 2013;82(6):1267-1271.
5. Novara G, Artibani W, Barber MD, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol. 2010;58(2):218-238.
6. Chermansky CJ, Winters JC. Complications of vaginal mesh surgery. Curr Opin Urol. 2012;22(4): 287-291.
7. Nilsson CG, Palva K, Aarnio R, Morcos E, Falconer C. Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J. 2013;24(8):1265-1269.
8. Chapple CR, Raz S, Brubaker L, Zimmern PE. Mesh sling in an era of uncertainty: lessons learned and the way forward. Eur Urol. 2013;64(4):525-529.
9. Hou JC, Alhalabi F, Lemack GE, Zimmern PE. Outcome of transvaginal mesh and tape removed for pain only. J Urol. 2014;192(3):856-860.
10. Blaivas JG, Mekel G. Management of urinary fistulas due to midurethral sling surgery. J Urol. 2014;192(4):1137-1142.
11. Deng DY, Rutman M, Raz S, Rodriguez LV. Presentation and management of major complications of midurethral slings: are complications under-reported? Neurourol Urodyn. 2007;26(1):46-52.
12. Dunn GE, Hansen BL, Egger MJ, et al. Changed women: the long-term impact of vaginal mesh complications. Female Pelvic Med Reconstr Surg. 2014;20(3):131-136.
13. MDL Statistics report: distribution of pending multidistrict lawsuit dockets by district. http://www.jpml.uscourts.gov./sites/jpml/files/Pending-MDL-Dockets-By-District-November-17-2014.pdf. Published 2014. Accessed March 7, 2015.
14. Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. http://www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/UCM262760.pdf. Published 2011. Accessed February 11, 2015.
15. Healthy Canadians Website. Surgical mesh: complications associated with transvaginal implantation for the treatment of stress urinary incontinence and pelvic organ prolapse-notice to hospitals. Recalls & alerts. http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39475a-eng.php. Published May 13, 2014. Accessed March 5, 2015.
16. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18(6):800-804.
17. Raina P, Torrance-Rynard V, Wong M, Woodward C. Agreement between self-reported and routinely collected health-care utilization data among seniors. Health Serv Res. 2002;37(3):751-774.
18. Williams J, Young W. Appendix I: a summary of studies on the quality of health care administrative databases in Canada. In: Goel V, Williams JI, Anderson GM, et al, eds. Patterns of Health Care in Ontario: the ICES Practice Atlas. 2nd ed. Ottawa, ON: Canadian Medical Association; 2000:339-347.
19. Jha P, Deboer D, Sykora K, Naylor CD. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol. 1996;27(6):1335-1342.
20. American Urologic Association. Guideline for the surgical management of female stress: urinary incontinence: update (2009). https://www.auanet.org/education/clinical-practice-guidelines.cfm. Published 2009. Revised 2012. Accessed March 25, 2015.
21. Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol. 2008;180(5):1890-1897.
22. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25(3):512-516.
23. Kralji B. Measuring "rurality" for purposes of health care planning: an empirical measure for Ontario. Ontario Med Rev. 2000;67(10):33-52.
24. Weiner J. The Johns Hopkins ACG System Reference Manual, Version 8.2. http://www.ensolution.se/upl/files/14429.pdf. Published December 2008. Accessed February 27, 2015.
25. Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011;49(10):932-939.
26. Matheson FI, Dunn JR, Smith KLW, Moineddin R, Glazier RH. Development of the Canadian Marginalization Index: a new tool for the study of inequality. Can J Public Health. 2012;103(8)(suppl 2):S12-S16.
27. Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38(6):1228-1234.
28. Pagano M, Gauvreau K. Principles of Biostatistics. 2nd ed. Pacific Grove, CA: Duxbury Press; 2000.
29. Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. Position statement on mesh midurethral slings for stress urinary incontinence. http://www.sufuorg.com/docs/guidelines/AUGS-SUFU-MUS-Position-Statement-APPROVED-1-3-2014.aspx. Published 2014. Accessed February 27, 2015.
30. Dmochowski RR, Blaivas JM, Gormley EA, et al; Female Stress Urinary Incontinence Update Panel of the American Urological Association Education and Research, Inc. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010;183(5):1906-1914.
31. Rice NT, Hu Y, Slaughter JC, Ward RM. Pelvic mesh complications in women before and after the 2011 FDA public health notification. Female Pelvic Med Reconstr Surg. 2013;19(6):333-338.
32. Jonsson Funk M, Siddiqui NY, Pate V, Amundsen CL, Wu JM. Sling revision/removal for mesh erosion and urinary retention: long-term risk and predictors. Am J Obstet Gynecol. 2013;208(1): 73.e1-73.e7. doi:10.1016/j.ajog.2012.10.006.
33. Novara G, Galfano A, Boscolo-Berto R, et al. Complication rates of tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials comparing tension-free midurethral tapes to other surgical procedures and different devices. Eur Urol. 2008;53(2):288-308.
34. Abed H, Rahn DD, Lowenstein L, Balk EM, Clemons JL, Rogers RG; Systematic Review Group of the Society of Gynecologic Surgeons. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J. 2011;22(7):789-798.
35. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349(22):2117-2127.
36. Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. Variations in stress incontinence and prolapse management by surgeon specialty. J Urol. 2007;178(4, pt 1):1411-1417.
37. Verbrugghe A, De Ridder D, Van der Aa F. A repeat mid-urethral sling as valuable treatment for persistent or recurrent stress urinary incontinence. Int Urogynecol J. 2013;24(6):999-1004.
38. Meyer F, Hermieu JF, Boyd A, et al. Repeat mid-urethral sling for recurrent female stress urinary incontinence. Int Urogynecol J. 2013;24(5): 817-822.
39. Patil A, Moran P, Duckett J; British Society of Urogynaecology Audit Committee. How do urogynaecologists treat failed suburethral slings? experience from the British Society of Urogynaecology database and literature review. J Obstet Gynaecol. 2011;31(6):514-517.
40. Raval MV, Wang X, Cohen ME, et al. The influence of resident involvement on surgical outcomes. J Am Coll Surg. 2011;212(5):889-898.
41. Patel HD, Ball MW, Cohen JE, Kates M, Pierorazio PM, Allaf ME. Morbidity of urologic surgical procedures: an analysis of rates, risk factors, and outcomes. Urology. 2015;85(3):552-559.